mci 9038 has been researched along with Morbid Obesity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bécanne, X; De Mesmay, M; Flaujac, C; Gauzit, R; Godier, A; Horellou, MH; Parisot, M; Samama, CM | 1 |
| Durr, EA; Krueger, CD; Shapiro, NL | 1 |
2 other study(ies) available for mci 9038 and Morbid Obesity
| Article | Year |
|---|---|
Argatroban and renal replacement therapy in a morbidly obese patient with heparin-induced thrombocytopenia: a case report.
Topics: Acute Kidney Injury; Adult; Anticoagulants; Arginine; Heparin; Humans; Male; Obesity, Morbid; Pipecolic Acids; Renal Replacement Therapy; Respiratory Distress Syndrome; Shock, Septic; Sulfonamides; Thrombocytopenia | 2010 |
Prolonged anticoagulation after discontinuation of argatroban and warfarin therapy in an obese patient with heparin-induced thrombocytopenia.
Topics: Adult; Anticoagulants; Arginine; Drug Therapy, Combination; Female; Gastric Bypass; Heparin; Humans; International Normalized Ratio; Obesity, Morbid; Partial Thromboplastin Time; Pipecolic Acids; Pulmonary Embolism; Sulfonamides; Thrombocytopenia; Treatment Outcome; Warfarin | 2006 |